LONDON, Feb 10, 2026 (BSS/AFP) - British pharmaceutical giant AstraZeneca on Tuesday said its net profit jumped 45 percent last year on strong sales of cancer drugs, as it zoned in on the United States.

Profit after tax rose to $10.2 billion in 2025 from $7 billion one year earlier, AstraZeneca said in a statement.